Skip to content

VITROS 1009406Recalls & reported problems

Ortho Clinical Diagnostics · VITROS Immunodiagnostic Products RE Controls · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10758750008322), received between Aug 27, 2024 and Aug 27, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • Foreign Body Sensation in Eye1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 27, 2024Use of Device Problem; Use of Device Problem

    THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) WAS CONTACTED TO REPORT A VITROS OPERATOR EXPERIENCED LEFT EYE PAIN POTENTIALLY CAUSED BY GLASS DUST THAT MAY HAVE ENTERED HIS LEFT EYE, PRODUCED BY A SHATTERED GLASS BOTTLE OF VITROS REPRODUCTIVE ENDOCRINE (RE) CONTROLS. THE OPERATOR IMMEDIATELY RINSED HIS EYE WITH WATER AND THEN SOUGHT MEDICAL TREATMENT. THE EYE DOCTOR WAS ABLE TO VERIFY THAT THE EYE, THOUGH INFLAMED, DID NOT CONTAIN ANY FOREIGN MATERIAL AND DID NOT LOOKED DAMAGED FROM SCRATCHING. PER MEDICAL CONSULTATION FROM MEDICAL SAFETY OFFICER (B)(6) DATED (B)(6) 2024: PER THE SDS, THE RE CONTROL CONTAINS HUMAN PLASMA, HUMAN CORD SERUM/PLASMA, AND KATHON (A CHEMICAL MIXTURE). DUE TO THE PRESENCE OF HUMAN BLOOD AND BLOOD PRODUCTS, THERE EXISTS THE RISK OF TRANSMISSION OF BLOOD-BORNE PATHOGENS UPON EXPOSURE TO THE BODY MUCOSA. DONORS AND DONATION BLOOD FOR ORTHO REAGENTS TESTED NEGATIVE PER CURRENT FDA-REQUIRED TESTS; THEREFORE, THE CHANCE OF BEING TRANSMITTED WITH THE COMMON BLOOD-BORNE PATHOGENS IS LOW. HOWEVER, NO TEST CAN GUARANTEE 100% DETECTION. SO, FOR PRECAUTION, THIS CASE IS CLASSIFIED AS SERIOUS INJURY. THE REAGENT IS ALSO LISTED AS AN EYE IRRITA

    Patient problems: Foreign Body Sensation in Eye

    MAUDE report 20080639 ↗

Other Multi-analyte controls, all kinds (assayed) devices

All Multi-analyte controls, all kinds (assayed) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.